Angiotensin type 2 receptor antagonism as a new target to manage gout.

Thiago Neves VieiraAndré L Lopes SaraivaRafaela Mano GuimarãesJoão Paulo Mesquita LuizLarissa Garcia PintoVeridiana de Melo Rodrigues ÁvilaLuiz Ricardo GoulartJair Pereira Cunha-JuniorPeter Anthony McNaughtonThiago Mattar CunhaJuliano FerreiraCassia Regina Silva

Published in: Inflammopharmacology (2022)

R may be a potential therapeutic option to manage gout arthritis.

Keyphrases

uric acid
rheumatoid arthritis
angiotensin ii
angiotensin converting enzyme
metabolic syndrome
binding protein